SCHEMBL8085680

SCHEMBL8085680

ClCCc1cccc(N2CCCCC2)n1

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 18/20 0.58
TRPV3 Q8NET8 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20548111 0.86 PDE10A (0.54) PDE10ATRPV3
SCHEMBL29228864 0.84 PDE10A (0.55) PDE10ATRPV3
SCHEMBL16516277 0.83 PDE10A (0.58) PDE10ATRPV3
SCHEMBL23207442 0.79 PDE10A (0.54) PDE10ATRPV3
SCHEMBL15537495 0.79 TRPV3 (0.58) PDE10ATRPV3
SCHEMBL10233469 0.79 PDE10A (0.57) PDE10ATRPV3
Hydrochloric Acid SCHEMBL30152537 0.78 PDE10A (0.52) PDE10ATRPV3
Hydrochloric Acid SCHEMBL23167793 0.78 PDE10A (0.52) PDE10ATRPV3
SCHEMBL6242988 0.78 HSD11B1 (0.50) PDE10ATRPV3
SCHEMBL6838679 0.78 HSD11B1 (0.50) PDE10ATRPV3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6133270-A Isothiazolones and pharmaceutical formulations WARNER-LAMBERT COMPANY (US) 2000-10-17 US disclosed
US-6001863-A USEFUL AS ANTIVIRAL, ANTIINFLAMMATORY AND ANTIATHEROSCLEROSIS AGENT; ADMINISTERING TO THE PATIENT IN NEED OF ZINC EJECTION FROM NUCLEOCAPSID PROTEIN WARNER-LAMBERT COMPANY (US) 1999-12-14 US disclosed
EP-0828488-A1 ISOTHIAZOLONES WARNER-LAMBERT COMPANY (US) 1998-03-18 EP disclosed
WO-1996038144-A1 ISOTHIAZOLONES WARNER-LAMBERT COMPANY (US) 1996-12-05 WO disclosed